Showing 2,371 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

FDA approves Janssen's HIV combination Symtuza

Editor's pick
Pharmaphorum
18 July 2018
Drug interactions & pharmacokinetics

Darunavir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1

Editor's pick
MHRA
18 July 2018
Pharmaceutical industry

Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug

Editor's pick
Seeking Alpha
18 July 2018
Retention & linkage to care

TAC: ARV treatment education best way to bring down HIV infection rates

Editor's pick
Eyewitness News
18 July 2018
PrEP

Reported 'PrEP Failure' in Thailand May Be a Missed Acute HIV Infection: Here's What You Need to Know

Editor's pick
TheBody PRO
17 July 2018
New & experimental HIV treatments

CytoDyn Announces Positive Results from Completed Pivotal PRO 140 HIV Combination Trial

Editor's pick
CytoDyn press release
17 July 2018
Pregnancy and vertical transmission

Dolutegravir preconception signal: time is up for shoddy surveillance

Editor's pick
HIV i-Base
16 July 2018
Adherence

Blood, Hair, or Urine? Weighing PrEP Adherence Options Beyond Self-Report

Editor's pick
The Body Pro
16 July 2018
Side effects

We Must Talk About Having Diarrhea. I’ll Go First.

Editor's pick
My Fabulous Disease
16 July 2018
Pregnancy and vertical transmission

Dolutegravir: need to consider all pros and cons before switching in pregnancy

Editor's pick
HIV i-Base
11 July 2018
HIV treatment

Reduced-Dose Darunavir Effective in Virologically Suppressed HIV-1

Editor's pick
Infectious Disease Advisor
4 July 2018
New & experimental HIV treatments

Abivax releases positive top line data from ABX464-005 phase 2a study in HIV infection

Editor's pick
Abivax press release
4 July 2018
People & personal stories

Nelson Vergel: Built to Survive

Editor's pick
Poz
29 June 2018
HIV prevention policy

'New York Times' To Condoms: Drop Dead

Editor's pick
HIV Plus
29 June 2018
Epidemiology & behaviour

Dispelling the Bad Myths about PrEP in that New York Times Op-Ed

Editor's pick
Jezebel
27 June 2018
Side effects

No association found between efavirenz, suicide risk

Editor's pick
Healio
26 June 2018
New & experimental HIV treatments

European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

Editor's pick
Gilead press release
25 June 2018
Vaginal rings & topical PrEP

First Multipurpose Gel Designed to Prevent HIV, HSV, and HPV Simultaneously in Women and Men Advances in Clinical Trials

Editor's pick
Population Council
25 June 2018
Pharmaceutical industry

GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

Editor's pick
Reuters
25 June 2018
Ageing & HIV

What is on the minds of PLHIV in Europe in terms of their long term health?

Editor's pick
EATG
25 June 2018
Side effects

New contraindication against using darunavir/cobicistat during pregnancy

Editor's pick
HIV i-Base
25 June 2018
Drug-resistant TB

All-access for blockbuster TB drug in South Africa

Editor's pick
Health-e
19 June 2018
New & experimental HIV treatments

GSK's two-drug HIV treatment meets main goal in late stage studies

Editor's pick
Reuters
15 June 2018
How HIV works

ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

Editor's pick
Infectious Disease Advisor
15 June 2018